Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Several medical societies backed the 2026 AAP childhood vaccine schedule, prioritizing longstanding scientific evidence for pediatric public health protocols.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

The between-group difference in restricted mean arthritis-free survival time seen at 2 years persisted at 4 years.

HealthDay News — Six-month smartwatch-based atrial fibrillation (AF) screening improves detection of new-onset AF among patients at elevated stroke risk, according to a study published online January ...

TNS seems safe, with no serious adverse events, but no significant differential treatment effects seen versus sham TNS ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.

HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...

Packaging defects in MediHoney and CVS Wound Gel products have led the FDA to issue a safety alert due to the risk of ...

Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.